Manulife (Manufacturers Life Insurance)’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$408K Buy
55,031
+16,365
+42% +$172K ﹤0.01% 2242
2025
Q4
$455K Sell
38,666
-4,885
-11% -$52.7K ﹤0.01% 2218
2025
Q3
$336K Sell
43,551
-21,453
-33% -$150K ﹤0.01% 2341
2025
Q2
$475K Buy
65,004
+2,238
+4% +$18.1K ﹤0.01% 2198
2025
Q1
$596K Sell
62,766
-4,751
-7% -$59.3K ﹤0.01% 2057
2024
Q4
$1.11M Sell
67,517
-2,170
-3% -$33.7K ﹤0.01% 1860
2024
Q3
$1.03M Sell
69,687
-908
-1% -$14.2K ﹤0.01% 1914
2024
Q2
$979K Buy
70,595
+2,904
+4% +$41.2K ﹤0.01% 1874
2024
Q1
$1.06M Buy
67,691
+4,464
+7% +$68.9K ﹤0.01% 1836
2023
Q4
$1.02M Sell
63,227
-1,320
-2% -$21.6K ﹤0.01% 1789
2023
Q3
$794K Buy
64,547
+13,130
+26% +$195K ﹤0.01% 1868
2023
Q2
$826K Sell
51,417
-96
-0.2% -$1.58K ﹤0.01% 1758
2023
Q1
$897K Buy
51,513
+190
+0.4% +$2.71K ﹤0.01% 1693
2022
Q4
$474K Buy
51,323
+1,407
+3% +$13.1K ﹤0.01% 2029
2022
Q3
$430K Sell
49,916
-819
-2% -$8.13K ﹤0.01% 2072
2022
Q2
$413K Buy
50,735
+3,589
+8% +$34.3K ﹤0.01% 2176
2022
Q1
$573K Sell
47,146
-10,581
-18% -$223K ﹤0.01% 2122
2021
Q4
$1.97K Sell
57,727
-238
-0.4% -$9.32K ﹤0.01% 1508
2021
Q3
$2.8M Sell
57,965
-5,691
-9% -$263K ﹤0.01% 1414
2021
Q2
$2.88M Buy
63,656
+2,857
+5% +$127K ﹤0.01% 1477
2021
Q1
$2.93M Sell
60,799
-1,616
-3% -$84.1K ﹤0.01% 1437
2020
Q4
$3.36M Buy
62,415
+2,738
+5% +$124K ﹤0.01% 1370
2020
Q3
$2.2M Sell
59,677
-1,839
-3% -$68.4K ﹤0.01% 1401
2020
Q2
$1.79M Buy
61,516
+1,108
+2% +$30.7K ﹤0.01% 1429
2020
Q1
$1.67M Buy
60,408
+3,317
+6% +$99.4K ﹤0.01% 1357
2019
Q4
$1.67M Buy
57,091
+427
+0.8% +$10.2K ﹤0.01% 1452
2019
Q3
$1.08M Buy
56,664
+2,260
+4% +$53K ﹤0.01% 1606
2019
Q2
$1.19M Buy
54,404
+680
+1% +$14.9K ﹤0.01% 1563
2019
Q1
$1.1M Buy
53,724
+14,439
+37% +$251K ﹤0.01% 1641
2018
Q4
$495K Sell
39,285
-3,132
-7% -$46.7K ﹤0.01% 1968
2018
Q3
$651K Sell
42,417
-126
-0.3% -$1.74K ﹤0.01% 2093
2018
Q2
$558K Sell
42,543
-1,684
-4% -$18.5K ﹤0.01% 2292
2018
Q1
$361K Sell
44,227
-485
-1% -$3.93K ﹤0.01% 2569
2017
Q4
$396K Sell
44,712
-219
-0.5% -$2.02K ﹤0.01% 2479
2017
Q3
$500K Sell
44,931
-1,314
-3% -$12.8K ﹤0.01% 2273
2017
Q2
$414K Buy
46,245
+3,058
+7% +$24.3K ﹤0.01% 2430
2017
Q1
$341K Buy
43,187
+5,614
+15% +$45.7K ﹤0.01% 2451
2016
Q4
$322K Sell
37,573
-151
-0.4% -$1.29K ﹤0.01% 2422
2016
Q3
$310K Sell
37,724
-531
-1% -$4.46K ﹤0.01% 2434
2016
Q2
$308K Buy
38,255
+523
+1% +$4.19K ﹤0.01% 2362
2016
Q1
$247K Sell
37,732
-1,438
-4% -$9.46K ﹤0.01% 2447
2015
Q4
$308 Hold
39,170
﹤0.01% 2345
2015
Q3
$225 Sell
39,170
-555
-1% -$3.44K ﹤0.01% 2559
2015
Q2
$215 Buy
+39,725
New +$205K ﹤0.01% 2787
2014
Q4
Sell
-2,010
Closed -$10 3999
2014
Q3
$10 Hold
2,010
﹤0.01% 3510
2014
Q2
$7K Sell
2,010
-26,108
-93% -$86.8K ﹤0.01% 3452
2014
Q1
$98 Hold
28,118
﹤0.01% 3069
2013
Q4
$102 Buy
28,118
+10,918
+63% +$37.9K ﹤0.01% 3061
2013
Q3
$51 Sell
17,200
-10,334
-38% -$29.1K ﹤0.01% 3129
2013
Q2
$109K Buy
+27,534
New +$105K ﹤0.01% 2984

Other funds holding NEO

Manulife (Manufacturers Life Insurance)'s NEO Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) increased its NeoGenomics (NEO) stake by 42% in Q1 2026, buying an estimated $172K and bringing the position to 55,031 shares worth $408K. The position accounts for ﹤0.01% of the portfolio, ranked #2242.

Manulife (Manufacturers Life Insurance) first reported a position in NEO in Q2 2013 and has held it in 50 quarters since. The position peaked at $3.36M in Q4 2020. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 55,031 shares of NeoGenomics worth $408K as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) bought 16,365 NeoGenomics shares in Q1 2026, an estimated $172K.
  • NeoGenomics made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2242 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in NeoGenomics in Q2 2013 and has held it in 50 quarters since.
  • Manulife (Manufacturers Life Insurance)'s NeoGenomics position peaked at $3.36M in Q4 2020.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.